CN Stock MarketDetailed Quotes

600511 China National Medicines Corporation

Watchlist
  • 33.49
  • -0.46-1.35%
Market Closed Dec 4 15:00 CST
25.27BMarket Cap11.67P/E (TTM)

China National Medicines Corporation Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
4.10%38.03B
2.55%24.76B
7.98%12.12B
9.23%49.7B
5.75%36.53B
9.70%24.14B
1.50%11.23B
-2.09%45.5B
0.73%34.54B
-0.31%22.01B
Operating revenue
4.10%38.03B
2.55%24.76B
7.98%12.12B
9.23%49.7B
5.75%36.53B
9.70%24.14B
1.50%11.23B
-2.09%45.5B
0.73%34.54B
-0.31%22.01B
Other operating revenue
----
24.07%51.28M
----
65.20%103.99M
----
680.16%41.33M
----
139.72%62.95M
----
-54.91%5.3M
Total operating cost
4.33%36.31B
2.68%23.63B
8.04%11.58B
9.20%47.19B
6.10%34.8B
9.79%23.01B
1.26%10.72B
-2.55%43.22B
0.36%32.8B
-0.73%20.96B
Operating cost
4.92%35.36B
3.27%23B
8.77%11.27B
9.67%45.7B
6.20%33.7B
9.79%22.27B
0.93%10.36B
-2.71%41.68B
0.32%31.74B
-0.70%20.29B
Operating tax surcharges
9.79%88.94M
24.61%57.35M
17.52%26.82M
2.51%114.74M
-2.53%81.01M
-12.11%46.02M
-31.11%22.82M
-6.74%111.93M
-4.32%83.12M
-0.19%52.36M
Operating expense
-14.58%582.15M
-18.09%388.69M
-15.37%201.45M
0.61%962.38M
0.67%681.55M
13.17%474.51M
21.42%238.03M
1.70%956.5M
1.58%677.03M
-3.15%419.28M
Administration expense
0.57%309.74M
-0.57%200.45M
-4.45%100.53M
7.23%467.13M
7.03%307.98M
8.10%201.61M
8.86%105.22M
4.75%435.62M
6.80%287.75M
9.76%186.5M
Financial expense
-218.13%-73.67M
-135.50%-52.69M
-25.98%-28.8M
-337.33%-126.13M
12.90%-23.16M
-9.76%-22.37M
-28.57%-22.86M
-57.24%-28.84M
-100.79%-26.59M
-328.65%-20.38M
-Interest expense (Financial expense)
-30.98%24.27M
-39.64%15.57M
-45.09%7.32M
17.46%31.57M
86.91%35.16M
89.92%25.79M
-4.82%13.33M
-38.51%26.88M
-53.57%18.81M
-48.78%13.58M
-Interest Income (Financial expense)
-45.21%-101.7M
-33.97%-73.51M
-4.91%-39.71M
-134.98%-166.37M
-24.26%-70.04M
-35.33%-54.87M
-10.56%-37.85M
-0.09%-70.8M
5.30%-56.36M
-0.05%-40.55M
Research and development
-16.98%44.14M
-16.14%28.8M
-16.44%13.94M
6.27%71.2M
21.24%53.17M
15.12%34.34M
24.15%16.68M
20.17%67M
11.66%43.85M
13.02%29.83M
Credit Impairment Loss
4.08%-46.64M
-8.39%-43.37M
-224.09%-30.18M
61.49%-9.17M
-17.04%-48.62M
-103.00%-40.01M
42.23%-9.31M
27.92%-23.8M
11.74%-41.54M
34.74%-19.71M
Asset Impairment Loss
68.32%-6.83M
57.07%-4.05M
45.89%-2.79M
107.56%388.87K
-107.58%-21.56M
1.58%-9.44M
-76.58%-5.16M
70.77%-5.14M
53.98%-10.39M
-48.71%-9.59M
Other net revenue
1.88%271.79M
4.20%199.11M
9.76%75.66M
6.64%442.4M
16.60%266.77M
35.61%191.08M
29.23%68.93M
25.74%414.85M
18.10%228.79M
68.07%140.91M
Fair value change income
----
----
----
--10.82M
--34.73M
--34.73M
----
----
----
----
Invest income
10.26%316.41M
21.71%240.33M
30.13%104.98M
23.09%358.95M
31.90%286.98M
48.94%197.45M
47.75%80.67M
2.92%291.62M
18.41%217.57M
37.64%132.57M
-Including: Investment income associates
-2.73%320.21M
10.05%243.25M
18.19%102.19M
19.89%456.54M
24.01%329.19M
34.29%221.04M
22.10%86.46M
0.15%380.8M
4.07%265.44M
12.63%164.59M
Asset deal income
-141.17%-136.75K
-111.75%-54.07K
97.72%-2.37K
-95.04%83.44K
-78.22%332.13K
5,435.12%460.36K
-3,795.40%-103.94K
2,460.84%1.68M
2,317.13%1.52M
45.28%-8.63K
Other revenue
-39.79%8.98M
-20.79%6.25M
28.87%3.65M
-45.96%81.32M
-75.80%14.92M
-79.03%7.9M
-84.05%2.84M
54.72%150.49M
-22.67%61.63M
55.64%37.65M
Operating profit
-0.23%1.99B
0.50%1.33B
7.02%613.8M
9.26%2.94B
1.20%1.99B
11.05%1.32B
9.21%573.52M
10.12%2.69B
9.28%1.97B
13.44%1.19B
Add:Non operating Income
-54.22%1.34M
-46.98%990.47K
-28.26%629.91K
-73.18%3.01M
61.87%2.93M
236.52%1.87M
84.17%878.08K
173.35%11.21M
-38.21%1.81M
-62.13%555.09K
Less:Non operating expense
132.04%24.77M
3,391.89%12.77M
189.27%892.27K
-9.71%16.47M
-24.06%10.67M
-94.28%365.57K
-61.76%308.45K
177.78%18.24M
375.54%14.06M
3,136.25%6.39M
Total profit
-1.02%1.97B
-0.50%1.32B
6.87%613.54M
9.04%2.93B
1.44%1.99B
11.72%1.32B
9.39%574.09M
9.94%2.69B
8.61%1.96B
12.74%1.19B
Less:Income tax cost
-3.28%390.91M
-2.93%254.16M
-4.26%118.42M
6.66%596.42M
-2.19%404.14M
3.50%261.83M
7.26%123.68M
8.30%559.18M
8.12%413.18M
15.58%252.98M
Net profit
-0.44%1.57B
0.09%1.06B
9.93%495.12M
9.67%2.33B
2.41%1.58B
13.95%1.06B
9.98%450.41M
10.38%2.13B
8.74%1.54B
12.00%932.6M
Net profit from continuing operation
-0.44%1.57B
0.09%1.06B
9.93%495.12M
9.67%2.33B
2.41%1.58B
13.95%1.06B
9.98%450.41M
10.38%2.13B
8.74%1.54B
12.00%932.6M
Less:Minority Profit
-21.70%93.66M
-19.12%63.16M
-0.93%35.66M
14.47%188.47M
5.77%119.61M
11.00%78.09M
0.90%36M
-5.60%164.65M
-4.96%113.09M
5.27%70.35M
Net profit of parent company owners
1.30%1.48B
1.62%1B
10.87%459.45M
9.26%2.15B
2.14%1.46B
14.19%984.58M
10.85%414.41M
11.97%1.96B
9.99%1.43B
12.59%862.25M
Earning per share
Basic earning per share
1.30%1.9632
1.62%1.3261
10.85%0.6089
9.27%2.8443
2.15%1.9381
14.18%1.3049
10.86%0.5493
11.97%2.6031
9.99%1.8974
12.59%1.1428
Diluted earning per share
1.30%1.9632
1.62%1.3261
10.85%0.6089
9.27%2.8443
2.15%1.9381
14.18%1.3049
10.86%0.5493
11.97%2.6031
9.99%1.8974
12.59%1.1428
Other composite income
-538.89%-4.45M
-1,222.22%-8.53M
-243.45%-5.85M
577.86%5.1M
140.00%1.01M
-72.16%759.79K
2,171.43%4.08M
61.53%-1.07M
54.31%-2.53M
178.86%2.73M
Other composite income of parent company owners
-538.89%-4.45M
-1,222.22%-8.53M
-243.45%-5.85M
577.86%5.1M
140.00%1.01M
-72.16%759.79K
2,171.43%4.08M
61.53%-1.07M
54.31%-2.53M
178.86%2.73M
Total composite income
-0.79%1.57B
-0.78%1.06B
7.65%489.27M
9.96%2.34B
2.64%1.58B
13.70%1.06B
11.03%454.49M
10.48%2.13B
8.98%1.54B
12.80%935.33M
Total composite income of parent company owners
0.92%1.48B
0.67%991.98M
8.39%453.6M
9.58%2.15B
2.39%1.46B
13.92%985.34M
12.00%418.49M
12.09%1.96B
10.26%1.43B
13.46%864.98M
Total composite income of minority owners
-21.70%93.66M
-19.12%63.16M
-0.93%35.66M
14.47%188.47M
5.77%119.61M
11.00%78.09M
0.90%36M
-5.60%164.65M
-4.96%113.09M
5.27%70.35M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 4.10%38.03B2.55%24.76B7.98%12.12B9.23%49.7B5.75%36.53B9.70%24.14B1.50%11.23B-2.09%45.5B0.73%34.54B-0.31%22.01B
Operating revenue 4.10%38.03B2.55%24.76B7.98%12.12B9.23%49.7B5.75%36.53B9.70%24.14B1.50%11.23B-2.09%45.5B0.73%34.54B-0.31%22.01B
Other operating revenue ----24.07%51.28M----65.20%103.99M----680.16%41.33M----139.72%62.95M-----54.91%5.3M
Total operating cost 4.33%36.31B2.68%23.63B8.04%11.58B9.20%47.19B6.10%34.8B9.79%23.01B1.26%10.72B-2.55%43.22B0.36%32.8B-0.73%20.96B
Operating cost 4.92%35.36B3.27%23B8.77%11.27B9.67%45.7B6.20%33.7B9.79%22.27B0.93%10.36B-2.71%41.68B0.32%31.74B-0.70%20.29B
Operating tax surcharges 9.79%88.94M24.61%57.35M17.52%26.82M2.51%114.74M-2.53%81.01M-12.11%46.02M-31.11%22.82M-6.74%111.93M-4.32%83.12M-0.19%52.36M
Operating expense -14.58%582.15M-18.09%388.69M-15.37%201.45M0.61%962.38M0.67%681.55M13.17%474.51M21.42%238.03M1.70%956.5M1.58%677.03M-3.15%419.28M
Administration expense 0.57%309.74M-0.57%200.45M-4.45%100.53M7.23%467.13M7.03%307.98M8.10%201.61M8.86%105.22M4.75%435.62M6.80%287.75M9.76%186.5M
Financial expense -218.13%-73.67M-135.50%-52.69M-25.98%-28.8M-337.33%-126.13M12.90%-23.16M-9.76%-22.37M-28.57%-22.86M-57.24%-28.84M-100.79%-26.59M-328.65%-20.38M
-Interest expense (Financial expense) -30.98%24.27M-39.64%15.57M-45.09%7.32M17.46%31.57M86.91%35.16M89.92%25.79M-4.82%13.33M-38.51%26.88M-53.57%18.81M-48.78%13.58M
-Interest Income (Financial expense) -45.21%-101.7M-33.97%-73.51M-4.91%-39.71M-134.98%-166.37M-24.26%-70.04M-35.33%-54.87M-10.56%-37.85M-0.09%-70.8M5.30%-56.36M-0.05%-40.55M
Research and development -16.98%44.14M-16.14%28.8M-16.44%13.94M6.27%71.2M21.24%53.17M15.12%34.34M24.15%16.68M20.17%67M11.66%43.85M13.02%29.83M
Credit Impairment Loss 4.08%-46.64M-8.39%-43.37M-224.09%-30.18M61.49%-9.17M-17.04%-48.62M-103.00%-40.01M42.23%-9.31M27.92%-23.8M11.74%-41.54M34.74%-19.71M
Asset Impairment Loss 68.32%-6.83M57.07%-4.05M45.89%-2.79M107.56%388.87K-107.58%-21.56M1.58%-9.44M-76.58%-5.16M70.77%-5.14M53.98%-10.39M-48.71%-9.59M
Other net revenue 1.88%271.79M4.20%199.11M9.76%75.66M6.64%442.4M16.60%266.77M35.61%191.08M29.23%68.93M25.74%414.85M18.10%228.79M68.07%140.91M
Fair value change income --------------10.82M--34.73M--34.73M----------------
Invest income 10.26%316.41M21.71%240.33M30.13%104.98M23.09%358.95M31.90%286.98M48.94%197.45M47.75%80.67M2.92%291.62M18.41%217.57M37.64%132.57M
-Including: Investment income associates -2.73%320.21M10.05%243.25M18.19%102.19M19.89%456.54M24.01%329.19M34.29%221.04M22.10%86.46M0.15%380.8M4.07%265.44M12.63%164.59M
Asset deal income -141.17%-136.75K-111.75%-54.07K97.72%-2.37K-95.04%83.44K-78.22%332.13K5,435.12%460.36K-3,795.40%-103.94K2,460.84%1.68M2,317.13%1.52M45.28%-8.63K
Other revenue -39.79%8.98M-20.79%6.25M28.87%3.65M-45.96%81.32M-75.80%14.92M-79.03%7.9M-84.05%2.84M54.72%150.49M-22.67%61.63M55.64%37.65M
Operating profit -0.23%1.99B0.50%1.33B7.02%613.8M9.26%2.94B1.20%1.99B11.05%1.32B9.21%573.52M10.12%2.69B9.28%1.97B13.44%1.19B
Add:Non operating Income -54.22%1.34M-46.98%990.47K-28.26%629.91K-73.18%3.01M61.87%2.93M236.52%1.87M84.17%878.08K173.35%11.21M-38.21%1.81M-62.13%555.09K
Less:Non operating expense 132.04%24.77M3,391.89%12.77M189.27%892.27K-9.71%16.47M-24.06%10.67M-94.28%365.57K-61.76%308.45K177.78%18.24M375.54%14.06M3,136.25%6.39M
Total profit -1.02%1.97B-0.50%1.32B6.87%613.54M9.04%2.93B1.44%1.99B11.72%1.32B9.39%574.09M9.94%2.69B8.61%1.96B12.74%1.19B
Less:Income tax cost -3.28%390.91M-2.93%254.16M-4.26%118.42M6.66%596.42M-2.19%404.14M3.50%261.83M7.26%123.68M8.30%559.18M8.12%413.18M15.58%252.98M
Net profit -0.44%1.57B0.09%1.06B9.93%495.12M9.67%2.33B2.41%1.58B13.95%1.06B9.98%450.41M10.38%2.13B8.74%1.54B12.00%932.6M
Net profit from continuing operation -0.44%1.57B0.09%1.06B9.93%495.12M9.67%2.33B2.41%1.58B13.95%1.06B9.98%450.41M10.38%2.13B8.74%1.54B12.00%932.6M
Less:Minority Profit -21.70%93.66M-19.12%63.16M-0.93%35.66M14.47%188.47M5.77%119.61M11.00%78.09M0.90%36M-5.60%164.65M-4.96%113.09M5.27%70.35M
Net profit of parent company owners 1.30%1.48B1.62%1B10.87%459.45M9.26%2.15B2.14%1.46B14.19%984.58M10.85%414.41M11.97%1.96B9.99%1.43B12.59%862.25M
Earning per share
Basic earning per share 1.30%1.96321.62%1.326110.85%0.60899.27%2.84432.15%1.938114.18%1.304910.86%0.549311.97%2.60319.99%1.897412.59%1.1428
Diluted earning per share 1.30%1.96321.62%1.326110.85%0.60899.27%2.84432.15%1.938114.18%1.304910.86%0.549311.97%2.60319.99%1.897412.59%1.1428
Other composite income -538.89%-4.45M-1,222.22%-8.53M-243.45%-5.85M577.86%5.1M140.00%1.01M-72.16%759.79K2,171.43%4.08M61.53%-1.07M54.31%-2.53M178.86%2.73M
Other composite income of parent company owners -538.89%-4.45M-1,222.22%-8.53M-243.45%-5.85M577.86%5.1M140.00%1.01M-72.16%759.79K2,171.43%4.08M61.53%-1.07M54.31%-2.53M178.86%2.73M
Total composite income -0.79%1.57B-0.78%1.06B7.65%489.27M9.96%2.34B2.64%1.58B13.70%1.06B11.03%454.49M10.48%2.13B8.98%1.54B12.80%935.33M
Total composite income of parent company owners 0.92%1.48B0.67%991.98M8.39%453.6M9.58%2.15B2.39%1.46B13.92%985.34M12.00%418.49M12.09%1.96B10.26%1.43B13.46%864.98M
Total composite income of minority owners -21.70%93.66M-19.12%63.16M-0.93%35.66M14.47%188.47M5.77%119.61M11.00%78.09M0.90%36M-5.60%164.65M-4.96%113.09M5.27%70.35M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data